Table 1.
Effects of training that are sensitive to 4EGI-1
| Figure | Variable (number/μm) | Direction of training effect | Training effect |
Drug effect |
Training × drug |
|||
|---|---|---|---|---|---|---|---|---|
| F | p | F | p | F | p | |||
| Vehicle group | Trained group | |||||||
| 2B | PR | ↑ | 5.78 | 0.02235 | 7.71 | 0.00910 | 7.80 | 0.00018 |
| 2C | Head PR | ↑ | 7.98 | 0.00821 | 13.75 | 0.00079 | 10.41 | 0.00001 |
| 2D | Sp without PR | ↓ | 5.63 | 0.02406 | 16.17 | 0.00033 | 6.99 | 0.00042 |
| 2D | Sp with head PR | ↑ | 6.19 | 0.01847 | 12.15 | 0.00145 | 8.87 | 0.00006 |
| 2E | PR (number/spine) | ↑ | 8.11 | 0.00477 | 4.05 | 0.04513 | 4.64 | 0.00338 |
| 2F | Sp with only head PR | ↑ | 6.11 | 0.01914 | 16.79 | 0.00027 | 10.61 | 0.00001 |
| 2G | Sp with multiple PR, head only | ↑ | 6.33 | 0.01725 | 2.55 | 0.11980 | 4.18 | 0.00943 |
| 3B | Sp with no PR, PSD < 0.05 μm2 | ↓ | 5.20 | 0.02965 | 14.81 | 0.00054 | 6.23 | 0.00095 |
| 3D | Sp with head PR, PSD < 0.05 μm2 | ↑ | 5.81 | 0.02210 | 11.20 | 0.00210 | 8.60 | 0.00008 |
| 3D | Sp with head PR, PSD > 0.2 μm2 | ↑ | 5.03 | 0.03220 | 6.05 | 0.01951 | 3.93 | 0.01261 |
| 4C | Sp with SA, head PR | ↑ | 4.58 | 0.04034 | 7.50 | 0.01000 | 4.85 | 0.00441 |
| 4D | Sp without SA, head PR | ↑ | 4.58 | 0.04034 | 11.13 | 0.00216 | 8.36 | 0.00010 |
| 5B | Sp with SA, no astro, head PR | ↑ | 5.62 | 0.02417 | 6.28 | 0.01750 | 5.83 | 0.00147 |
| 5E | Sp without SA, with astro, head PR | ↑ | 5.63 | 0.02403 | 5.15 | 0.03012 | 5.37 | 0.00244 |
| Drug group | Box group | |||||||
| 5E | Sp without SA, with astro, no PR | ↑ | 6.94 | 0.01360 | 0.64 | 0.43049 | 9.80 | 0.00002 |
Shown is a summary of measures that had significant (p < 0.05) training × drug interactions with training effects in only one of the drug conditions. Nonsignificant effects are shown in italics. PR, Polyribosomes; Sp, spine; astro, perisynaptic astroglia.